A team of scientists at the U.S. Department of Energy’s (DOE) Brookhaven National Laboratory and Columbia University has demonstrated a way to produce large quantities of the receptor that SARS-CoV-2, the virus that causes COVID-19, binds to on the surface of human cells.
US DoD grants $2.3m to Immuron for military version of anti-diarrhoeal Travelan – Pharmaceutical Technology
The DoD states that infectious diarrhoea is the most common illness that US troops deployed overseas experience. Image credit: Shutterstock / Andrew Angelov. Immuron Limited
August 19, 2024